It is our mission to secure Indiana’s position as a global leader in life sciences by advocating, connecting, promoting, and delivering tangible benefits on behalf of our diverse corporate members.
IHIF members are eligible for discounts and savings on a wide variety of products and services geared towards life sciences companies and general business needs. From lab supplies and insurance to office supplies and credit cards, there is something here for most every company. Explore your options and enjoy the benefits of being an IHIF member!
Industry Surveys - Help Please! We Need Your Input!
Thank you to everyone who has already completed one of our short but important industry surveys! If you have not already responded, please take just a few minutes to provide your thoughts and some vital data that will help us, help you in the coming months and years!
Compass 2025 Survey

IHIF is kicking off it's next statewide strategic plan! In keeping with past efforts, we like to begin by asking for your feedback on the issues and challenges that concern you the most and hear your ideas on what might be the best solutions. Given the challenges of the pandemic, we are also interested in hearing how that has affected your business planning. We are seeking broad input from all corners and sectors of the life sciences industry in Indiana, so please take just a few minutes to complete a brief survey! Compass 2025 will be presented in the fall and the results will be used to help direct IHIF programming and actions.
Medical Manufacturing Space Survey

The Indiana Health Industry Forum is conducting a survey to inventory laboratory and cleanroom space in Indiana. Without a measurement of these capabilities, Indiana is missing out on inclusion in national rankings of life sciences clusters, opportunities to attract new companies to the state, opportunities to grow existing businesses, and the ability to call for the creation of new investment tax credits.

Responses are optional. Any data collected will be used in the aggregate for a benchmarking report.

This survey is best completed by someone familiar with your facility’s design, layout, workflow and operations.  
BioFutures 2022 – Reserve Ad Space Now

The Indiana Health Industry Forum (IHIF), in partnership with Indianapolis Business Journal, will publish the 2022 BioFutures Magazine, a round-up of the latest news from the state’s thriving health and life sciences sectors.

This year’s BioFutures Magazine will be inserted in the March 18, 2022, issue of IBJ and will reach business decision makers throughout central Indiana and beyond. BioFutures is also the primary marketing piece used by IHIF as it promotes Indiana’s health science sector at events locally, nationally, and around the world.

Learn More and download rate flyer
IHIF Launching Technology Commercialization Forum -
Announces Kick-off Webinar
The Technology Commercialization Forum is an opportunity for IHIF members with an interest in the topic to connect with one another and drive a conversation around de-risking life sciences technologies.

Please join us for the Kick-off Presentation/WEBINAR*
October 21, 11 am – noon

“De-risking Medical Devices and Ensuring Patient Safety With Appropriate Controls“
Justin Renfrow, Contracts Director
Justin Metcalf, Engineering Director

*IHIF Membership requirement waived for this initial presentation
Indianapolis- based Elevate Ventures has landed a $400,000 grant from the U.S. Department of Commerce’s Economic Development Administration.
The grant, plus a $600,000 local match, will establish a fund called the Development of Indiana-Centric Venture-Syndicates, or DIV. DIV will co-invest with local, regional and national venture capital firms investing in Indiana startups. Elevate Ventures was one of 50 organizations around the country that received a total of $36.5 million in grants as part of the Build to Scale program, which aims to accelerate technology entrepreneurship. One other Indiana entity also received a grant: Bloomington-based Dimension Mill received $399,650. (Source: IBJTech)
IHIF's Policy Corner
What We're Following at Home and on the Hill

RICKS: Price Controls Would Mean Cuts at Lilly
As Congress considers a proposal to allow Medicare to negotiate prescription drug prices, Eli Lilly and Co. (NYSE: LLY) Chief Executive Officer Dave Ricks is warning the move would have a devastating impact on the pharmaceutical industry. “A cut like is being proposed would have about a 40% reduction in our U.S. revenues,” said Ricks, who adds that would mean deep cuts in research and development spending and fewer jobs in Indiana. “There is no way we could just absorb that. We would have to make significant changes to our operations.” Read More (Source: Inside Indiana Business)
The FDA has finalized five new questions and answers about biosimilar development and the Biologics Price Competition and Innovation Act. The agency also revised the draft guidance on the topic, and it now includes one question and answer explaining how developers can prove their proposed injectable biosimilar or interchangeable product has comparable strength to the reference drug.
Full Story: Regulatory Focus (9/20)  (Source: Bio SmartBrief)
Member News
Thrive Well Seeks Pharma Partners for CBD Research
Thrive Well LLC, a division of Kocolene Development Corporation (KDC), recently partnered with the Indiana Health Industry Forum (IHIF) in an effort to further grow connections with the life sciences business community. The company is capable of producing high purity CBD oils and extracts suitable for use in pharmaceuticals, cosmetics, and food grade products.
Learn More (Source: Thrive Well and IHIF)
Amplified Sciences Earns Most Fundable Company Designation by Pepperdine Graziadio Business School

Amplified Sciences, Inc. is thrilled to announce that it is among 16 startups to be recognized on the Pepperdine Graziadio Business School’s fourth annual Most Fundable Companies® List. Amplified Sciences competed against over 3,300 early-stage US companies and was named in the silver category among the winners. The Most Fundable Companies initiative aims to educate founders on the investor diligence process and recognize exceptional entrepreneurs who are solving today’s problems with inventive solutions and are also seeking investment capital to fuel their company's growth.

Learn More (Source: Amplified Sciences)
Patricia Clark awarded NIH Pioneer Award, the first in Indiana
Patricia L. Clark, the Rev. John Cardinal O’Hara, C.S.C., Professor of Chemistry and Biochemistry and associate vice president for research at the University of Notre Dame, has received a Director’s Pioneer Award from the National Institutes of Health. These awards are given to exceptionally creative scientists advancing high-risk, high-impact research. Clark is the first researcher in Indiana to receive this distinguished award since the program’s inception in 2004.
Learn More (Source: University of Notre Dame)
Researchers from the University of Notre Dame and the University of Florida have developed a sensor that could diagnose a heart attack in less than 30 minutes, according to a study published in Lab on a Chip. 
Learn More (Source: University of Notre Dame)
Inotiv, Inc. and Envigo Propose to Join Forces to Enhance Research and Drug Discovery Solutions
West Lafayette-based Inotiv Inc. (Nasdaq: NOTV) has announced plans to acquire Envigo RMS Holding Corp., headquartered in Indianapolis, in a $545 million cash and stock deal. The contract research organization says the deal will provide one location for drug developers to access products and services.
Learn More (Source: Inside Indiana Business)
Inotiv Acquires Colorado Biopharma Company
West Lafayette-based Inotiv Inc. (Nasdaq: Inotiv) has acquired Plato BioPharma Inc., an in vivo pharmacology research and drug discovery company in Colorado. Inotiv says the deal, valued at $15 million in cash and stock, will bolster its growing operations in the Boulder, Colorado area. Read More (Source: Inside Indiana Business)
Inotiv Founder Named Watanabe Award Winner
The board of directors for BioCrossroads has named Dr. Peter Kissinger, founder of West Lafayette-based Inotiv Inc. (Nasdaq: NOTV), the recipient of the 2021 August M. Watanabe Life Sciences Champion of the Year Award. Kissinger also spent more than 40 years as a professor of chemistry at Purdue University.

Read More (Source: BioCrossroads and Inside Indiana Business)
IU, Ivy Tech Add New Guaranteed Admissions Agreements
Indiana University Bloomington and Ivy Tech Community College have created new guaranteed admissions agreements for five programs, creating additional pathways for students to continue their bachelor's degree. The agreements will allow Ivy Tech students who have earned specific associate degrees to transfer as juniors and choose from nine related baccalaureate programs at IU Bloomington. The programs include four in psychology, two in biology and one each in elementary education, informatics and criminal justice.
Learn More (Source: Insidne Indiana Business)
Exelead Inc., with headquarters at 6925 Guion Road on the northwest side, said it has manufactured and shipped tens of millions of doses of the Pfizer-BioNTech vaccine in recent months and is expanding its facilities to keep up with demand. 
More (Source: IBJ - subscription required)
OpenTrons – Laboratory Automation Solutions
Promotional Offer for IHIF Members: FREE pipette with OT-2 robot order!
Introducing the OT-2, your personal pipetting robot.
Lab-Crafters showcases our I-FLEX System, showing you all it can do. It truly allows for quick change as your lab requirements change.

This animated video will take you through all the features of an individual bench. 

Please reach out to Betsy Fouts with any questions, suggestions, or comments. 
Industry News
Groundbreaking for Fishers Life Sciences Facility
Governor Eric Holcomb will joined officials from the city of Fishers and Italy-based Stevanato Group to break ground on a 370,000-square-foot life sciences facility. The company says it is investing $145 million to construct a state-of-the-art plant which will manufacture vials and syringes for pharmaceutical companies. 
Read More (Source: Inside Indiana Business)
Medical Mask Maker Growing Footprint
A respiratory mask maker on the west side of Indianapolis has broken ground on a 35,000-square-foot expansion of its facility as it continues to respond to market demand and as a hedge against supply chain disruptions. Pulmodyne Inc. manufactures airway and respiratory medical devices, such as masks, used in conjunction with ventilators. When Inside INdiana Business first talked to the company in April 2020, as it responded to the global healthcare crisis, it had just leased 7,000-square-feet in warehouse space near its factory. Read More (Source: Inside Indiana Business)
Healthcare Logistics Firm Expanding Indiana Footprint
A logistics company that already operates three facilities in central Indiana has announced plans to open a fourth and create up to 100 jobs by early next year. Texas-based Life Sciences Logistics says the 440,000-square-foot cold storage facility will be located in the Hendricks County town of Clayton. Read More (Source: Inside Indiana Business)
COVID Updates
Additional manufacturing sites have been approved by the European Medicines Agency for mRNA-based COVID-19 vaccines by Moderna and Pfizer/BioNTech to boost production. Two sites were approved for Pfizer/BioNTech's Comirnaty vaccine in the EU, while the EMA also cleared an additional site for Moderna in Bloomington, Ind.
Full Story: Reuters (8/24)  
IEDC Loosens Requirements for Restart Program
The state is updating eligibility requirements for small businesses to receive federal pandemic relief funding. Our partners at WIBC report the Indiana Economic Development Corp. still has $30 million in CARES Act funding to provide grants before the deadline at the end of the year. Read More (Source: Inside Indiana Business)
Welcome New IHIF Members!
Follow IHIF on Twitter to keep up with all of the latest news, events, and exclusive member benefits!

Featured New Member
Bristol Myers Squibb is committed to discovering, developing and delivering transformational medicines in areas where we believe we have an opportunity to make a meaningful difference for patients: oncology, immuno-science, cardiovascular and fibrosis.

Upcoming Events
Kelley Conference Series
Kelley IN Life Sciences
Collaboration Series
2021 – 2022 Conference Series

Since 2006, the Center for the Business of Life Sciences at the IU Kelley School of Business (CBLS) has been presenting the Indiana Life Sciences Collaboration Conference Series, providing a forum for professionals in healthcare and life sciences to consider, discuss, and debate key business strategy issues. The conferences bring together leaders from industry, academia, government, and economic development communities. Join us in exploring business solutions and making new connections in the life sciences.


The CBLS has missed gathering with corporate partners and friends in the industry! This year, in response, the plan is to offer a hybrid series – in person conferences while streaming the events so attendees may also join virtually. The registration page provides options for in person or virtual registration.

Cybersecurity in Healthcare & the Life Sciences
November 19, 2021

Impact of the New Administration: HHS, FDA, CMS
February 18, 2022

The Potential of AI & Smart Devices in Healthcare
April 29, 2022

Please join us for the
IMDMC Annual Meeting

Join us at the IMDMC Annual Meeting on Thursday, November 11, 2021 from 9:30 am to 2:30 pm at Launch Fishers. Details regarding speakers and topics will be shared when finalized.
IMDMC Member Attendee – $100
Non-Member Attendee – $150
We look forward to seeing you all soon!

BIO International Convention Call For Sessions is Now Open
Mark your calendar for the BIO International Convention, June 13-16, 2022, in San Diego! Call for Sessions is now open.
Do you want to showcase your latest findings in front of 17,000+ innovators in biotechnology and life sciences? Does your company have a compelling story to tell about innovative research or projects? This is your chance to submit topics that paint a vision for the global biotechnology industry's future in San Diego, June 13–16, 2022.
BIO is seeking speakers who inspire others to dream big, tackle what some might think is impossible and go beyond to create a better future. We are looking for leaders who are forward thinking, diverse, engaging and who drive meaningful discussions about what’s next for the biotechnology industry. Speaking at BIO allows you to establish yourself as an international expert, build critical dialogue, spark creative conversations, profile new technology, and more.
Click here to learn more about 2022 BIO International Convention.
Extended: Proposal submissions will be accepted through October 21, 2021, so don't miss out on your opportunity to participate.
Venture Summit Virtual Connect
Startups \ Investors \ Matchmaking
December 7th – 9th 2021
Whether you’re a founder seeking capital and exposure, or an investor seeking new deals, Venture Summit \ Virtual Connect presented by youngStartup Ventures – is the event of the year you won’t want to miss.

A highly productive 3-day venture conference, this exclusive summit is dedicated to showcasing early stage VCs, Corporate VCs and angel investors committed to funding venture backed, emerging and early stage Lifesciences, Healthcare and MedTech companies as well as showcasing over 100 Top Innovators.

Special offer: Register Now & Save 20% off (Use discount code “IHIFVIP”)
SBIR Contracts are research and development funding opportunities with specific NIH-proposed activities and deliverables. This year, National Cancer Institute released 16 topics ranging from health IT to radiation technology. Interested small businesses can submit a proposal through the electronic Contract Proposal Submission (eCPS) website by 5 p.m. EDT on October 28, 2021. For more information about the FY 2022 Contract Solicitation, visit the NCI SBIR current contracts website.
We are pleased to announce the release of the NCI Annual Plan & Budget Proposal for Fiscal Year 2023. 
Each year, developing this plan provides us with a special opportunity to reflect on progress in cancer research and consider how best to direct our resources in the years ahead, on behalf of the American public. 
 This plan focuses on our enduring top priority — accelerating cancer research — and features four special scientific topics: clinical trials, computer-based drug design, precision prevention, and tumor dynamics. 
Small Business Funding for Innovations in Alzheimer's Disease and Aging
The National Institute on Aging (NIA) offers early-stage funding opportunities to small businesses and researchers looking to commercialize innovative treatments or technologies to help people enjoy healthier lives as they age. NIA's Office of Small Business Research is accepting applications for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) funding. Learn more about these open opportunities. The next deadline to apply is January 5, 2022
BIO Business Solutions - Special Discounts for IHIF Members
BIO Business Solutions provides cost-savings offers to eligible IHIF Members. To learn more about the programs and services available, please click here. Not an IHIF member? Join today! See the latest deals and offers from our BIO Business Solutions partners here
Featured Program
BIO Business Solutions® has selected Chubb as its endorsed insurer due to their total insurance solutions for risks specific to life science companies. For more than 25 years, Chubb has been providing cost-effective risk management and insurance protection tailored to the unique needs of biotechnology companies. Chubb's products include property and casualty, product liability, clinical trial liability, errors and omissions liability, professional liability, and cyber liability insurance. Chubb personnel specialize in the biotech market; they understand the issues and develop tailored solutions.
IHIF Member Benefits

Property and Casualty Insurance:
  • Competitive premiums for companies at all stages
  • Low minimum premiums for early stage companies
  • Dedicated loss control and claims specialists for members
  • Access to proprietary tools to assist in developing insurance values
Clinical Trials, Errors and Omissions, Product, and Professional Liability Cyber Insurance:
  • 10% premium credit (subject to regulatory limitations)
Accelerate Discovery with the New Nikon AX/AX R Confocal Microscopes
BIO Business Solutions is excited to announce that its preferred partner, Nikon, has released their 10th generation of confocal microscope: the AX and AX R.
The AX and AX R are the first confocal systems to combine a large 25 mm field of view with 8192 x 8192-pixel resolution imaging for high throughput imaging – more detailed data can be captured in every image.

Exclusive Nikon Benefits for IHIF Members
Enjoy up to 38% off and Limited Extended Warranties for the new Nikon AX Systems. Click here to learn more!

If your company has not already signed up for the BIO-Nikon program, please email or click here to learn more about BIO Business Solutions for IHIF members.

About IHIF Membership

Now is a great time to become a member of the Indiana Health Industry Forum! Join your voice to over 150 current member companies to impact the strategic direction of Indiana's health science sector.

Membership in IHIF offers a number of solutions:
  • Promote your business, locally, nationally, and globally.
  • Support the industry in the state and contribute directly to its growth and direction.
  • Find others who share your interests and build your business network.
  • Lend your voice to public policies that support innovation.
  • Directly impact your bottom line with significant savings and discount programs exclusively for IHIF members.

To complete a membership application, click here. 
Time to renew? Try it on-line! It's quick and easy! IHIF members can renew their memberships on-line at any time and update information in the Member Directory. Not an IHIF Member? Apply on-line or download an application packet now!